These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27534158)

  • 1. [Platelets in coronary thrombosis].
    Goto S
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():118-24. PubMed ID: 27534158
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a pivotal role of platelets in vascular reocclusion and restenosis.
    LeBreton H; Topol E; Plow EF
    Cardiovasc Res; 1996 Feb; 31(2):235-6. PubMed ID: 8730399
    [No Abstract]   [Full Text] [Related]  

  • 3. CardioPulse: Platelet inhibitors and their differences.
    Gurbel PA; Tantry US
    Eur Heart J; 2016 Jan; 37(4):323-6. PubMed ID: 26795932
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary thrombosis as an etiology of woven coronary artery.
    Shi LL; Peng WX; Hi XZ; Bi HL; Li J
    J Biol Regul Homeost Agents; 2020 Jul-Aug,; 34(4):1501-1503. PubMed ID: 32885627
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet interactions as therapeutic targets for prevention of atherothrombosis.
    Smid J; Braun-Dullaeus R; Gawaz M; Langer HF
    Future Cardiol; 2009 May; 5(3):285-96. PubMed ID: 19450054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of platelet response to antiplatelet drugs. An important clue for cardiologists and cardiosurgeons].
    Bochenek T; Wilczyński M; Wita K; Lelek M; Trusz-Gluza M; Bochenek A
    Kardiol Pol; 2007 Oct; 65(10):1266-9. PubMed ID: 17979060
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel antithrombotic strategies in cardiovascular diseases.
    Golino P; Loffredo F; Riegler L; Renzullo E; Cocchia R
    Curr Opin Investig Drugs; 2005 Mar; 6(3):298-306. PubMed ID: 15816507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The success of warfarin treatment for coronary thrombosis in a young patient with acute coronary syndrome.
    Topsakal R; Kaya MG; Ozdogru I; Topuz M; Inanc T; Dogan A; Ergin A
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):117-8. PubMed ID: 18160583
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.
    Gawaz M
    Cardiovasc Res; 2004 Feb; 61(3):498-511. PubMed ID: 14962480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antithrombotic drugs for systemic and local delivery for coronary artery disease.
    Shah PK
    J Interv Cardiol; 1995 Aug; 8(4):427-37. PubMed ID: 10155257
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant and antiplatelet drugs.
    Lincoff AM
    Catheter Cardiovasc Interv; 2001 Dec; 54(4):514-20. PubMed ID: 11747192
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
    Gurbel PA; DiChiara J; Tantry US
    Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of platelets in coronary artery disease.
    Malý J; Pidrman V; Pecka M; Vodicková L; Hamet A; Siroký O; Bláha M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(4):407-15. PubMed ID: 6599817
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New directions in antiplatelet therapy.
    Ferreiro JL; Angiolillo DJ
    Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary atherothrombotic disease: progress in antiplatelet therapy.
    Badimon L; Vilahur G
    Rev Esp Cardiol; 2008 May; 61(5):501-13. PubMed ID: 18462654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment].
    Melandri G; Semprini F; Cervi V; Candiotti N; Branzi A
    Cardiologia; 1994 Dec; 39(12 Suppl 1):347-52. PubMed ID: 7634295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy: an unrecognized risk factor for coronary stent thrombosis?
    Hobson AR; McKenzie DB; Kunadian V; Purcell I; Zaman A; Dawkins KD; Curzen N
    J Invasive Cardiol; 2008 Apr; 20(4):E120-3. PubMed ID: 18398242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
    Boztosun B; Gunes Y; Kirma C; Barutcu I
    Int J Cardiol; 2006 Mar; 108(1):114-6. PubMed ID: 16516705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.